Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SEC14 like lipid binding 2 | 0.494 | 0.885 | 2.9E-08 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1989 | 2019 | ||||||||
|
lysosomal associated membrane protein 1 | 0.542 | 0.769 | 0.87 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1989 | 2019 | ||||||||
|
immunoglobulin heavy variable 1-12 (pseudogene) | 0.569 | 0.654 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1989 | 1994 | |||||||||
|
RAB8A, member RAS oncogene family | 0.610 | 0.577 | 0.98 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
phenotype | 0.400 | None | 0.979 | 322 | 2 | 1990 | 2020 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.400 | None | 0.981 | 100 | 0 | 1990 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.400 | None | 0.980 | 98 | 0 | 1990 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.959 | 72 | 0 | 1990 | 2019 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
phenotype | 0.100 | None | 0.969 | 62 | 0 | 1990 | 2019 | ||||||||
|
cathepsin D | 0.478 | 0.846 | 9.2E-04 |
|
phenotype | 0.100 | None | 1.000 | 20 | 1 | 1990 | 2019 | ||||||||
|
chromogranin A | 0.490 | 0.808 | 3.0E-02 |
|
phenotype | 0.100 | None | 0.867 | 15 | 0 | 1990 | 2020 | ||||||||
|
cytidine/uridine monophosphate kinase 2 | 0.663 | 0.615 | 1.1E-06 |
|
phenotype | 0.100 | None | 0.923 | 13 | 0 | 1990 | 2019 | ||||||||
|
cytidine/uridine monophosphate kinase 1 | 0.626 | 0.577 | 0.85 |
|
phenotype | 0.100 | None | 0.846 | 13 | 0 | 1990 | 2019 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 1990 | 2017 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 1990 | 2019 | ||||||||
|
integrator complex subunit 2 | 0.590 | 0.654 | 1.00 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 1990 | 2017 | ||||||||
|
eukaryotic translation initiation factor 3 subunit A | 0.592 | 0.769 | 1.00 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1990 | 2018 | ||||||||
|
matrix Gla protein | 0.539 | 0.846 | 3.6E-05 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1990 | 1992 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.600 | None | 0.936 | 565 | 13 | 1991 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 0.952 | 207 | 7 | 1991 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.400 | None | 0.971 | 34 | 0 | 1991 | 2019 | ||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
phenotype | 0.100 | None | 1.000 | 21 | 0 | 1991 | 2019 | ||||||||
|
integrin subunit alpha 2 | 0.522 | 0.731 | 6.3E-11 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 1991 | 2019 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 1991 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 1991 | 2018 |